JP2022115986A5 - - Google Patents

Download PDF

Info

Publication number
JP2022115986A5
JP2022115986A5 JP2022076621A JP2022076621A JP2022115986A5 JP 2022115986 A5 JP2022115986 A5 JP 2022115986A5 JP 2022076621 A JP2022076621 A JP 2022076621A JP 2022076621 A JP2022076621 A JP 2022076621A JP 2022115986 A5 JP2022115986 A5 JP 2022115986A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
seq
variable region
chain variable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022076621A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022115986A (ja
JP7348987B2 (ja
Filing date
Publication date
Priority claimed from PCT/IB2017/056831 external-priority patent/WO2018083628A1/en
Application filed filed Critical
Publication of JP2022115986A publication Critical patent/JP2022115986A/ja
Publication of JP2022115986A5 publication Critical patent/JP2022115986A5/ja
Application granted granted Critical
Publication of JP7348987B2 publication Critical patent/JP7348987B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022076621A 2016-11-03 2022-05-06 ピログルタメートアミロイド-βに対する抗体及びその使用 Active JP7348987B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662416788P 2016-11-03 2016-11-03
US62/416,788 2016-11-03
PCT/IB2017/056831 WO2018083628A1 (en) 2016-11-03 2017-11-02 ANTIBODIES TO PYROGLUTAMATE AMYLOID-β AND USES THEREOF
JP2019522704A JP7071349B2 (ja) 2016-11-03 2017-11-02 ピログルタメートアミロイド-βに対する抗体及びその使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019522704A Division JP7071349B2 (ja) 2016-11-03 2017-11-02 ピログルタメートアミロイド-βに対する抗体及びその使用

Publications (3)

Publication Number Publication Date
JP2022115986A JP2022115986A (ja) 2022-08-09
JP2022115986A5 true JP2022115986A5 (https=) 2023-02-08
JP7348987B2 JP7348987B2 (ja) 2023-09-21

Family

ID=60473574

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019522704A Expired - Fee Related JP7071349B2 (ja) 2016-11-03 2017-11-02 ピログルタメートアミロイド-βに対する抗体及びその使用
JP2022076621A Active JP7348987B2 (ja) 2016-11-03 2022-05-06 ピログルタメートアミロイド-βに対する抗体及びその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019522704A Expired - Fee Related JP7071349B2 (ja) 2016-11-03 2017-11-02 ピログルタメートアミロイド-βに対する抗体及びその使用

Country Status (11)

Country Link
US (3) US10519223B2 (https=)
EP (1) EP3534937B1 (https=)
JP (2) JP7071349B2 (https=)
CN (1) CN109922826A (https=)
AR (1) AR110114A1 (https=)
AU (1) AU2017355596A1 (https=)
CA (1) CA3041969A1 (https=)
ES (1) ES2962767T3 (https=)
MA (1) MA46704A (https=)
TW (1) TW201827467A (https=)
WO (1) WO2018083628A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201827467A (zh) * 2016-11-03 2018-08-01 比利時商健生藥品公司 焦穀胺酸類澱粉蛋白-β之抗體及其用途
CN111201030B (zh) 2017-07-25 2024-11-01 真和制药有限公司 通过阻断tim-3和其配体的相互作用治疗癌症
JP7110560B2 (ja) * 2017-09-06 2022-08-02 株式会社三洋物産 遊技機
JP7110561B2 (ja) * 2017-09-06 2022-08-02 株式会社三洋物産 遊技機
JP7110563B2 (ja) * 2017-09-06 2022-08-02 株式会社三洋物産 遊技機
JP2019136430A (ja) * 2018-02-15 2019-08-22 株式会社三洋物産 遊技機
JP2019136429A (ja) * 2018-02-15 2019-08-22 株式会社三洋物産 遊技機
JP2019136431A (ja) * 2018-02-15 2019-08-22 株式会社三洋物産 遊技機
WO2020160156A2 (en) 2019-01-30 2020-08-06 Immutics, Inc. Anti-gal3 antibodies and uses thereof
JP7207517B2 (ja) * 2019-03-01 2023-01-18 株式会社島津製作所 App669-711の測定方法、及び測定用キット
JOP20210265A1 (ar) * 2019-03-26 2023-01-30 Janssen Pharmaceutica Nv الأجسام المضادة لبيروغلوتامات أميلويد بيتا واستخداماتها
EP4157338A4 (en) 2020-05-26 2024-11-13 TrueBinding, Inc. METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING
KR20230039734A (ko) 2020-07-23 2023-03-21 오타이르 프로테나 리미티드 항-Aβ 항체
TW202300517A (zh) 2021-03-12 2023-01-01 美商美國禮來大藥廠 抗類澱粉β抗體及其用途
WO2022251048A1 (en) 2021-05-24 2022-12-01 Eli Lilly And Company Anti-amyloid beta antibodies and uses thereof
JP2023105292A (ja) * 2022-07-21 2023-07-28 株式会社三洋物産 遊技機
JP2023105293A (ja) * 2022-07-21 2023-07-28 株式会社三洋物産 遊技機
PE20252307A1 (es) 2022-12-22 2025-09-22 Bioarctic Ab Anticuerpo que se une a abetape3
WO2025037271A1 (en) 2023-08-17 2025-02-20 Janssen Pharmaceutica Nv Plasma assay for detecting cns-derived tau peptides
WO2025228316A1 (en) * 2024-04-28 2025-11-06 Jacobio Pharmaceuticals Co., Ltd. Anti-n3pglu amyloid beta antibodies and uses thereof
WO2025262228A1 (en) 2024-06-20 2025-12-26 Bioarctic Ab Bispecific binding molecule
CN118459582B (zh) * 2024-07-11 2024-11-15 苏州近岸蛋白质科技股份有限公司 一种抗焦谷氨酸修饰的β淀粉样蛋白抗体及其用途

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
FI941572A7 (fi) 1991-10-07 1994-05-27 Oncologix Inc Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenete lmä
US5642870A (en) 1992-08-05 1997-07-01 Sargis; Ike Switch stand
US5761894A (en) 1996-09-25 1998-06-09 Magic Circle Corporation Grass striping attachment for lawn mowers
US9907485B2 (en) 2004-10-15 2018-03-06 Brainlab Ag Targeted immunization and plaque destruction against Alzheimer's disease
US8691224B2 (en) * 2005-11-30 2014-04-08 Abbvie Inc. Anti-Aβ globulomer 5F7 antibodies
HRP20140049T1 (hr) 2007-01-05 2014-02-28 University Of Zürich Anti beta-amiloid antitijela i njihova upotreba
US8613923B2 (en) 2007-06-12 2013-12-24 Ac Immune S.A. Monoclonal antibody
EP2321348A2 (en) 2008-07-09 2011-05-18 University of Zürich Method of promoting neurogenesis
WO2010009987A2 (en) * 2008-07-21 2010-01-28 Probiodrug Ag Diagnostic antibody assay
WO2011016238A1 (en) * 2009-08-06 2011-02-10 Immunas Pharma, Inc. Antibodies that specifically bind to a beta oligomers and use thereof
WO2011151076A2 (en) * 2010-06-04 2011-12-08 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin MONOCLONAL ANTIBODIES TARGETING Αβ OLIGOMERS
WO2012021475A2 (en) * 2010-08-12 2012-02-16 Eli Lilly And Company ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF
PL3042917T3 (pl) * 2010-08-12 2018-07-31 Eli Lilly And Company Przeciwciała przeciwko peptydowi beta amyloidu N3pGlu i ich zastosowanie
EP2511296A1 (en) 2011-04-12 2012-10-17 Araclón Biotech, S. L. Antibody, kit and method for determination of amyloid peptides
ITRM20120383A1 (it) 2012-03-20 2013-09-21 Uni Degli Studi Di Milano B Icocca Metodo e kit per la rivelazione di anticorpi.
WO2015175769A1 (en) * 2014-05-15 2015-11-19 Biogen Ma Inc. Methods for the detection of amyloid beta oligomers in biological samples
WO2015191825A1 (en) 2014-06-13 2015-12-17 Biogen Ma Inc. Methods for the detection and measurement of amyloid beta in biological samples
JP2018501482A (ja) 2014-12-19 2018-01-18 プロビオドルグ エージー pGlu−Abetaペプチドの検出のための新規の方法
CA2992386A1 (en) 2015-07-16 2017-01-19 Probiodrug Ag Humanized antibodies
JOP20170004B1 (ar) 2016-01-15 2022-09-15 Lilly Co Eli الأجسام المضادة لببتيد بيتا النشوي مضاد N3pGlu واستخداماته
AR107774A1 (es) 2016-03-16 2018-05-30 Lilly Co Eli Terapia de combinación, método para el tratamiento de la enfermedad de alzheimer
EP3249388A1 (en) 2016-05-23 2017-11-29 Raman Health Technologies, S.L Method for diagnosing alzheimer´s disease
CN114796481A (zh) 2016-06-07 2022-07-29 生物基因国际神经科学有限责任公司 治疗阿尔茨海默病的方法
CA3032692A1 (en) 2016-08-09 2018-02-15 Eli Lilly And Company Combination antibody therapy for the treatment of neurodegenerative diseases
AR110470A1 (es) 2016-10-21 2019-04-03 Lilly Co Eli Terapia de combinación para tratar la enfermedad de alzheimer
TW201827467A (zh) * 2016-11-03 2018-08-01 比利時商健生藥品公司 焦穀胺酸類澱粉蛋白-β之抗體及其用途
TWI789644B (zh) 2017-04-20 2023-01-11 美商美國禮來大藥廠 抗-N3pGlu類澱粉β肽抗體及其用途
CN118370815A (zh) 2017-08-22 2024-07-23 渤健马萨诸塞州股份有限公司 含有抗β淀粉样蛋白抗体的药物组合物

Similar Documents

Publication Publication Date Title
JP2022115986A5 (https=)
TWI424162B (zh) 結合抗澱粉狀蛋白β肽抗體之抗遺傳性型抗體
US10114028B2 (en) Biomarkers for pneumonia and acute decompensated heart failure
CN102947707B (zh) 前胃泌素和肝病理
JP7105970B1 (ja) SARS-CoV-2の免疫測定方法及び免疫測定キット
JP2020516603A5 (https=)
CN102159591A (zh) 单克隆抗体和使用所述单克隆抗体的免疫测定法
O'Kennedy et al. Don't blame it all on antibodies–The need for exhaustive characterisation, appropriate handling, and addressing the issues that affect specificity
CN116348769A (zh) 用于检测tau蛋白病或淀粉样蛋白形成性疾病的基于血液的测定
JP2020189843A5 (https=)
RU2019110953A (ru) Моноклональное антитело, специфически связывающееся с тиоредоксином-1, и его применение
JP5380303B2 (ja) 高分子アディポネクチン測定法
JP2025504411A (ja) 唾液試料中のタウタンパク質を検出する方法
JP7416485B2 (ja) スイッチング結合剤、その製造方法、及びそれを用いた薬学組成物、検査キット及び抗原と抗体との分析方法
US20220260593A1 (en) Targets and methods of diagnosing, monitoring and treating frontotemporal dementia
CN110352351B (zh) 使用抗人bnp片段(4-32)抗体的免疫测定方法
US11313865B2 (en) Nucleic acids encoding anti-HcTNT-N69 antibodies
KR102397684B1 (ko) 항체의 항원 결합 부위에 결합하는 펩티드 및 이를 이용한 분석 방법
WO2018132639A1 (en) Methods and kits for the diagnosis and/or prognosis of ocular cicatricial pemphigoid
CN118234864A (zh) 抗EphA4抗体
JP5553603B2 (ja) 新規肝癌マーカー
WO2017188312A1 (ja) 抗医薬品抗体の測定方法
CA2771954A1 (en) Pneumonia biomarkers
JP7207517B2 (ja) App669-711の測定方法、及び測定用キット
KR102051052B1 (ko) 메르스 코로나바이러스 단백질에 특이적인 단클론 항체 및 그 용도